Equity Overview
Price & Market Data
Price: $0.854
Daily Change: $0.00 / 0.00%
Daily Range: $0.656 - $0.933
Market Cap: $19,113,944
Daily Volume: 1,970,864
Performance Metrics
1 Week: 23.05%
1 Month: 4.63%
3 Months: 9.94%
6 Months: -37.65%
1 Year: -27.61%
YTD: 9.94%
Company Details
Employees: 23
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.